APA (7th ed.) Citation

Zarka, J., Juthani, R., Sartor, O., Muniz, M., Kase, A. M., Riaz, I. B., . . . Jacene, H. (2026). LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 24(4), N.PAG. https://doi.org/10.1016/j.clgc.2026.102552

Chicago Style (17th ed.) Citation

Zarka, Jabra, et al. "LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer." Clinical Genitourinary Cancer 24, no. 4 (2026): N.PAG. https://doi.org/10.1016/j.clgc.2026.102552.

MLA (9th ed.) Citation

Zarka, Jabra, et al. "LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer." Clinical Genitourinary Cancer, vol. 24, no. 4, 2026, p. N.PAG, https://doi.org/10.1016/j.clgc.2026.102552.